Abecma, Breyanzi, CARVYKTI, Kymriah, Tecartus, Yeskarta
Human-Based CAR T Cell Therapy: Breakthroughs and Challenges
Introduction In the domain of oncology, immunotherapy has emerged as a pioneering methodology, harnessing the body's immune system to combat malignant tumors. There are many immunotherapeutic approaches, but Chimeric Antigen Rece..
Kite, Kymriah, Novartis, Yeskarta
CAR NK therapy has an effective rate of 73%
Immunotherapy in treatment of cancerCancer CAR-NK therapy has an effective rate of 73%, and is being recruited in domestic clinical trials.Immunotherapy has revolutionized the way cancer is treated. Cancer immunotherapy is divide..